Validation of glutathione quantitation from STEAM spectra against edited 1H NMR spectroscopy at 4T: application to schizophrenia.
about
Oxidative stress in schizophreniaIn vivo assessment of neurotransmitters and modulators with magnetic resonance spectroscopy: application to schizophreniaNegative correlation between brain glutathione level and negative symptoms in schizophrenia: a 3T 1H-MRS studyMolecular substrates of schizophrenia: homeostatic signaling to connectivityT2 relaxation effects on apparent N-acetylaspartate concentration in proton magnetic resonance studies of schizophrenia.Imaging glutamate in schizophrenia: review of findings and implications for drug discovery.A guide to the metabolic pathways and function of metabolites observed in human brain 1H magnetic resonance spectra.Advances in high-field magnetic resonance spectroscopy in Alzheimer's diseaseOxidative stress and schizophrenia: recent breakthroughs from an old storyMeta-analysis of oxidative stress in schizophrenia.(1)H MRS detection of glycine residue of reduced glutathione in vivoDecreased glutathione levels and impaired antioxidant enzyme activities in drug-naive first-episode schizophrenic patients.Oxidative stress in schizophrenia: an integrated approach.Sulfur amino acid-free diet results in increased glutamate in human midbrain: a pilot magnetic resonance spectroscopic study.Noninvasive quantification of human brain antioxidant concentrations after an intravenous bolus of vitamin C.Sensitivity and specificity of human brain glutathione concentrations measured using short-TE (1)H MRS at 7 T.Glutathione metabolism in the prefrontal brain of adults with high-functioning autism spectrum disorder: an MRS study.Reproducibility of phase rotation STEAM at 3T: focus on glutathione.HERMES: Hadamard encoding and reconstruction of MEGA-edited spectroscopy.Targeting of NMDA receptors in new treatments for schizophrenia.Echo time optimization for J-difference editing of glutathione at 3T.Genetic Polymorphism Associated Prefrontal Glutathione and Its Coupling With Brain Glutamate and Peripheral Redox Status in Early PsychosisBrain neurochemical and hemodynamic findings in the NY1DD mouse model of mild sickle cell disease.Quantification of glutathione in the human brain by MR spectroscopy at 3 Tesla: Comparison of PRESS and MEGA-PRESS.The use of magnetic resonance spectroscopy for assessing the effect of diet on cognition.Application of phase rotation to STRESS localization scheme at 3 T.Low tumor glutathione level as a sensitivity marker for glutamate-cysteine ligase inhibitors.Glutathione, the Major Redox Regulator, in the Prefrontal Cortex of Individuals at Clinical High Risk for Psychosis.
P2860
Q24595660-35B894A1-AA27-4CD8-A03C-D9082A685C92Q28083121-62F50BF2-EC80-4A61-9CD6-817CB88BA0BEQ28472479-3411FFA3-78C7-4BCF-B0C8-5F1BC786F100Q30383611-AFAA809C-1D00-4269-B990-7C95C700D9DEQ30648464-E2BD3C07-478A-44DD-B993-608B9FE94817Q30685335-CCFE3E94-3FFC-42CB-8A31-48AF60984EF0Q30698264-EC878D93-62F5-4BCF-A760-963F533556C2Q30770751-614836E3-7549-47D4-9BE5-1B0B4B2012F1Q30774039-DA26E02F-B561-41A8-95F0-9F4C97E1BC57Q33601360-9F16FC22-D3F7-45E7-86A3-4497871C4503Q33639213-17BFDA45-6519-45B4-9C81-6EAB2E2E358DQ33979025-B5B416EA-DEAF-44E1-A0B6-EB21B8F89857Q34494844-2C949F51-3DD3-4A51-AD01-D5F2C1E148F8Q35740204-161797FA-7B31-40A5-B251-23C0846E6A25Q35910783-9BCEA209-AF1A-4E3F-AA94-FFA272269A84Q36803821-66232D3F-503A-4979-997B-348E27FB53C6Q37700799-B108760A-F9F8-406E-88F2-217528526BA0Q37716923-B4C00255-8F38-4064-A47D-F7957641A328Q37742566-B3679A93-AB5F-45B3-9453-FC5FA15E7AFBQ38223276-9DCB97F9-9630-4E6D-AA5C-96C3FE419041Q39966232-4912E26D-3621-48D0-A271-122869D8B704Q41703320-B1CEE14E-5F21-438F-8752-996AEEE50D43Q42505511-99F8167E-562A-4E1A-AC85-CA77C0D20558Q43006340-1FE7069D-D7A9-426A-945F-4AC85907554EQ48091363-604EBA7C-6765-4A82-82FC-6D8594090C19Q48581079-8F5A0E77-EA04-4A45-9915-9E2DFB03C943Q55164552-8F8AFCA6-6D0A-45B9-8C6F-C5A8C2549D66Q55262427-1368224B-3026-4791-BF79-9561B9DE6204
P2860
Validation of glutathione quantitation from STEAM spectra against edited 1H NMR spectroscopy at 4T: application to schizophrenia.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Validation of glutathione quan ...... application to schizophrenia.
@en
Validation of glutathione quan ...... application to schizophrenia.
@nl
type
label
Validation of glutathione quan ...... application to schizophrenia.
@en
Validation of glutathione quan ...... application to schizophrenia.
@nl
prefLabel
Validation of glutathione quan ...... application to schizophrenia.
@en
Validation of glutathione quan ...... application to schizophrenia.
@nl
P2093
P1476
Validation of glutathione quan ...... application to schizophrenia.
@en
P2093
Kelvin O Lim
Melissa Terpstra
S Charles Schulz
T J Vaughan
P2888
P304
P356
10.1007/S10334-005-0012-0
P577
2005-11-18T00:00:00Z